소아 이비인후과 시장 규모, 점유율 및 동향 분석 보고서 : 제품별, 지역별, 부문별 예측(2024-2030년)

Pediatric ENT Market Growth & Trends:

The global pediatric ENT market size is anticipated to reach at USD 10.17 billion by 2030 and is projected to grow at a CAGR of 5.02% from 2024 to 2030, according to a new report by Grand View Research, Inc. There is an increasing emphasis on early diagnosis and treatment of ENT disorders in children. This awareness drives parents and healthcare providers to seek out advanced diagnostic devices and treatment options, further propelling market growth.

Recent advancements in cochlear implants for pediatric patients include the introduction of the Cochlear Nucleus 8 Sound Processor, which received FDA approval for use in children aged 9 to 24 months in November 2022. This processor is noteworthy for being the most powerful and smallest Behind-The-Ear (BTE) cochlear implant sound processor available, and it has Bluetooth LE Audio technology, allowing direct audio connectivity to consumer electronics. This innovation aims to enhance the listening experience for children by automatically adjusting to environmental changes and reducing background noise during conversations.

Themarket is experiencing growth, significantly influenced by recent FDA approvals and initiatives aimed at enhancing the availability of medical devices specifically designed for children. In December 2023, Acclarent became the first and only company to receive FDA clearance for a new treatment option for children requiring repeat ear tubes.

Pediatric ENT Market Report Highlights:

• The diagnostic ENT devices segment led the market with the largest revenue share of 57.15% in 2023. The hearing implant segment is expected to grow at the fastest CAGR during the forecast period. This can be attributed to the increasing preference for cochlear implants as non-invasive methods.
• North America dominated the market with the revenue share of 34.14% in 2023, owing to improving digital health infrastructure, rising healthcare expenditure, and presence of major ENT device manufacturers.
• The FDA is actively promoting the development and approval of pediatric medical devices, recognizing the unique needs of children. This includes increasing the number of devices labeled for pediatric use and involving pediatric experts in advisory panels to ensure safety and efficacy for younger populations.
• In August 2023, Phonak launched new advancements for its Lumity platform to better cater to individuals with untreated hearing loss in one ear and teens, children, and adults those with severe-to-severe hearing loss.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources
  • 1.5.4. Primary Research
• 1.6. Information Analysis
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Data Visualization
• 1.8. Model Details
  • 1.8.1. Commodity Flow Analysis
• 1.9. List of Secondary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. High prevalence of hearing loss
    • 3.2.1.2. Increasing penetration of minimally invasive pediatric ENT procedures
    • 3.2.1.3. Technological advancements in pediatric ENT devices
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High cost of hearing devices
    • 3.2.2.2. The absence of adequate reimbursement for certain ENT procedures
• 3.3. Business Environment Analysis
  • 3.3.1. Porter's Five Forces Analysis
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTLE Analysis

Chapter 4. Pediatric ENT Market: Product Estimates & Trend Analysis

• 4.1. Product Segment Dashboard
• 4.2. Product Market Share, 2023 & 2030
• 4.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
• 4.4. Diagnostic ENT Devices
  • 4.4.1. Diagnostic ENT devices market estimates and forecasts, 2018 - 2030 (USD Million)
• 4.5. Surgical ENT Devices
  • 4.5.1. Surgical ENT devices market estimates and forecasts, 2018 - 2030 (USD Million)
• 4.6. Hearing Aids
  • 4.6.1. Hearing aids market estimates and forecasts, 2018 - 2030 (USD Million)
• 4.7. Hearing Implants
  • 4.7.1. Hearing implants market estimates and forecasts, 2018 - 2030 (USD Million)
• 4.8. Nasal Splints
  • 4.8.1. Nasal splints market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 5. Pediatric ENT Market Regional Estimates & Trend Analysis

• 5.1. Regional Market Dashboard
• 5.2. Regional Market: Key Takeaways
• 5.3. North America
  • 5.3.1. North America pediatric ENT market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.3.2. U.S.
    • 5.3.2.1. Key country dynamic
    • 5.3.2.2. Regulatory framework
    • 5.3.2.3. Competitive insights
    • 5.3.2.4. U.S. pediatric ENT market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.3.3. Canada
    • 5.3.3.1. Key country dynamic
    • 5.3.3.2. Regulatory framework
    • 5.3.3.3. Competitive insights
    • 5.3.3.4. Canada pediatric ENT market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.3.4. Mexico
    • 5.3.4.1. Key country dynamic
    • 5.3.4.2. Regulatory framework
    • 5.3.4.3. Competitive insights
    • 5.3.4.4. Mexico pediatric ENT market estimates and forecasts, 2018 - 2030 (USD Million)
• 5.4. Europe
  • 5.4.1. Europe pediatric ENT market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.4.2. Germany
    • 5.4.2.1. Key country dynamic
    • 5.4.2.2. Regulatory framework
    • 5.4.2.3. Competitive insights
    • 5.4.2.4. Germany pediatric ENT market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.4.3. UK
    • 5.4.3.1. Key country dynamic
    • 5.4.3.2. Regulatory framework
    • 5.4.3.3. Competitive insights
    • 5.4.3.4. UK pediatric ENT market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.4.4. France
    • 5.4.4.1. Key country dynamic
    • 5.4.4.2. Regulatory framework
    • 5.4.4.3. Competitive insights
    • 5.4.4.4. France pediatric ENT market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.4.5. Italy
    • 5.4.5.1. Key country dynamic
    • 5.4.5.2. Regulatory framework
    • 5.4.5.3. Competitive insights
    • 5.4.5.4. Italy pediatric ENT market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.4.6. Spain
    • 5.4.6.1. Key country dynamic
    • 5.4.6.2. Regulatory framework
    • 5.4.6.3. Competitive insights
    • 5.4.6.4. Spain pediatric ENT devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.4.7. Denmark
    • 5.4.7.1. Key country dynamic
    • 5.4.7.2. Regulatory framework
    • 5.4.7.3. Competitive insights
    • 5.4.7.4. Denmark pediatric ENT devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.4.8. Sweden
    • 5.4.8.1. Key country dynamic
    • 5.4.8.2. Regulatory framework
    • 5.4.8.3. Competitive insights
    • 5.4.8.4. Sweden pediatric ENT devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.4.9. Norway
    • 5.4.9.1. Key country dynamic
    • 5.4.9.2. Regulatory framework
    • 5.4.9.3. Competitive insights
    • 5.4.9.4. Norway pediatric ENT devices market estimates and forecasts, 2018 - 2030 (USD Million)
• 5.5. Asia Pacific
  • 5.5.1. Asia Pacific pediatric ENT devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.5.2. Japan
    • 5.5.2.1. Key country dynamic
    • 5.5.2.2. Regulatory framework
    • 5.5.2.3. Competitive insights
    • 5.5.2.4. Japan pediatric ENT devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.5.3. China
    • 5.5.3.1. Key country dynamic
    • 5.5.3.2. Regulatory framework
    • 5.5.3.3. Competitive insights
    • 5.5.3.4. China pediatric ENT devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.5.4. India
    • 5.5.4.1. Key country dynamic
    • 5.5.4.2. Regulatory framework
    • 5.5.4.3. Competitive insights
    • 5.5.4.4. India pediatric ENT devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.5.5. South Korea
    • 5.5.5.1. Key country dynamic
    • 5.5.5.2. Regulatory framework
    • 5.5.5.3. Competitive insights
    • 5.5.5.4. South Korea pediatric ENT devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.5.6. Australia
    • 5.5.6.1. Key country dynamic
    • 5.5.6.2. Regulatory framework
    • 5.5.6.3. Competitive insights
    • 5.5.6.4. Australia pediatric ENT devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.5.7. Thailand
    • 5.5.7.1. Key country dynamic
    • 5.5.7.2. Regulatory framework
    • 5.5.7.3. Competitive insights
    • 5.5.7.4. Thailand pediatric ENT devices market estimates and forecasts, 2018 - 2030 (USD Million)
• 5.6. Latin America
  • 5.6.1. Latin America pediatric ENT devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.6.2. Brazil
    • 5.6.2.1. Key country dynamic
    • 5.6.2.2. Regulatory framework
    • 5.6.2.3. Competitive insights
    • 5.6.2.4. Brazil pediatric ENT devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.6.3. Argentina
    • 5.6.3.1. Key country dynamic
    • 5.6.3.2. Regulatory framework
    • 5.6.3.3. Competitive insights
    • 5.6.3.4. Argentina pediatric ENT devices market estimates and forecasts, 2018 - 2030 (USD Million)
• 5.7. MEA
  • 5.7.1. MEA pediatric ENT devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.7.2. South Africa
    • 5.7.2.1. Key country dynamic
    • 5.7.2.2. Regulatory framework
    • 5.7.2.3. Competitive insights
    • 5.7.2.4. South Africa pediatric ENT devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.7.3. Saudi Arabia
    • 5.7.3.1. Key country dynamic
    • 5.7.3.2. Regulatory framework
    • 5.7.3.3. Competitive insights
    • 5.7.3.4. Saudi Arabia pediatric ENT devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.7.4. UAE
    • 5.7.4.1. Key country dynamic
    • 5.7.4.2. Regulatory framework
    • 5.7.4.3. Competitive insights
    • 5.7.4.4. UAE pediatric ENT devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.7.5. Kuwait
    • 5.7.5.1. Key country dynamic
    • 5.7.5.2. Regulatory framework
    • 5.7.5.3. Competitive insights
    • 5.7.5.4. Kuwait pediatric ENT devices market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 6. Competitive Landscape

• 6.1. Participant Overview
• 6.2. Company Market Position Analysis
• 6.3. Company Categorization
• 6.4. Strategy Mapping
• 6.5. Company Profiles/Listing
  • 6.5.1. Medtronic
    • 6.5.1.1. Overview
    • 6.5.1.2. Financial performance
    • 6.5.1.3. Service benchmarking
    • 6.5.1.4. Strategic initiatives
  • 6.5.2. Karl Storz
    • 6.5.2.1. Overview
    • 6.5.2.2. Financial performance
    • 6.5.2.3. Product benchmarking
    • 6.5.2.4. Strategic initiatives
  • 6.5.3. Stryker Corporation
    • 6.5.3.1. Overview
    • 6.5.3.2. Financial performance
    • 6.5.3.3. Product benchmarking
    • 6.5.3.4. Strategic initiatives
  • 6.5.4. Smith & Nephew plc
    • 6.5.4.1. Overview
    • 6.5.4.2. Financial performance
    • 6.5.4.3. Product benchmarking
    • 6.5.4.4. Strategic initiatives
  • 6.5.5. Olympus Corporation
    • 6.5.5.1. Overview
    • 6.5.5.2. Financial performance
    • 6.5.5.3. Product benchmarking
    • 6.5.5.4. Strategic initiatives
  • 6.5.6. Cochlear Ltd.
    • 6.5.6.1. Overview
    • 6.5.6.2. Financial performance
    • 6.5.6.3. Product benchmarking
    • 6.5.6.4. Strategic initiatives
  • 6.5.7. Demant A/S
    • 6.5.7.1. Overview
    • 6.5.7.2. Financial performance
    • 6.5.7.3. Product benchmarking
    • 6.5.7.4. Strategic initiatives
  • 6.5.8. GN Store Nord A/S
    • 6.5.8.1. Overview
    • 6.5.8.2. Financial performance
    • 6.5.8.3. Product benchmarking
    • 6.5.8.4. Strategic initiatives
  • 6.5.9. Ambu A/S
    • 6.5.9.1. Overview
    • 6.5.9.2. Financial performance
    • 6.5.9.3. Product benchmarking
    • 6.5.9.4. Strategic initiatives
  • 6.5.10. Pentax Medical
    • 6.5.10.1. Overview
    • 6.5.10.2. Financial performance
    • 6.5.10.3. Product benchmarking
    • 6.5.10.4. Strategic initiatives
  • 6.5.11. FUJIFILM Holdings
    • 6.5.11.1. Overview
    • 6.5.11.2. Financial performance
    • 6.5.11.3. Product benchmarking
    • 6.5.11.4. Strategic initiatives
  • 6.5.12. Acclarent
    • 6.5.12.1. Overview
    • 6.5.12.2. Financial performance
    • 6.5.12.3. Product benchmarking
    • 6.5.12.4. Strategic initiatives
  • 6.5.13. Preceptis Medical
    • 6.5.13.1. Overview
    • 6.5.13.2. Financial performance
    • 6.5.13.3. Product benchmarking
    • 6.5.13.4. Strategic initiatives